Garuda Therapeutics (Garuda), a biotechnology company creating off-the-shelf, HSC therapies for a multitude of blood disorders, today announced the successful completion of an approximately $50 ...

a Japan-based Global Specialty Pharmaceutical Company. This investment underscores the growing need for an immediate, off-the-shelf and cost-effective solution to stem cell transplants.

Ltd., a Japan-based Global Specialty Pharmaceutical Company. This investment underscores the growing need for an immediate, off-the-shelf and cost-effective solution to stem cell transplants. Garuda's ...